News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Butler John P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2023 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 38,259 shares
@ $0.8775, valued at
$33.6k
Sold 47,239 shares
@ $0.8775, valued at
$41.5k
Sold 6,370 shares
@ $0.8775, valued at
$5.6k
|
|
| 03/01/2023 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 38,632 shares
@ $0.8132, valued at
$31.4k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
4
| Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 7,500 options to buy
@ $4.44, valued at
$33.3k
|
|
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.21, valued at
$78.2k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2019 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $3.44, valued at
$172k
|
|
| 06/13/2019 |
4
| Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.5, valued at
$202.5k
|
|
| 06/05/2019 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Exercised 287,000 options to buy
@ $0.47, valued at
$134.9k
|
|
| 12/13/2018 |
4
| Butler John P. (CEO & President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 135,697 shares
@ $8.94, valued at
$1.2M
|
|
| 08/22/2018 |
4
| Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $6.4306, valued at
$32.2k
|
|
| 07/12/2018 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Exercised 100,000 options to buy
@ $0.47, valued at
$47k
|
|
| 06/07/2018 |
4
| Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $11.3, valued at
$169.5k
|
|
| 04/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2018 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 88,900 shares
@ $0
Granted 126,300 options to buy
@ $14.3, valued at
$1.8M
|
|
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/02/2016 |
4
| Butler John P. (Director) has filed a Form 4 on Relypsa Inc|
Txns:
| Unknown transaction of 2,849 shares
@ $32, valued at
$91.2k
Disposed/sold 2,250 shares
@ $32, valued at
$72k
Disposed/sold 24,632 options to buy
@ $11, valued at
$271k
Disposed/sold 3,828 options to buy
@ $23.96, valued at
$91.7k
Disposed/sold 4,500 options to buy
@ $35.79, valued at
$161.1k
Disposed/sold 4,500 options to buy
@ $17, valued at
$76.5k
|
|
| 06/23/2016 |
4
| Butler John P. (Director) has filed a Form 4 on Relypsa Inc|
Txns:
| Granted 2,250 shares
@ $0
Granted 4,500 options to buy
@ $17, valued at
$76.5k
|
|
| 06/08/2016 |
4
| Butler John P. (Director) has filed a Form 4 on Relypsa Inc|
Txns:
| Sold 1,013 shares
@ $19.3192, valued at
$19.6k
|
|
| 05/27/2016 |
4
| Butler John P. (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $5.71, valued at
$171.3k
|
|
|
|